经会阴多参数MRI-超声融合靶向活检联合标准模板提高前列腺癌检出率
本研究纳入301例接受经会阴标准20针模板联合mpMRI-超声融合靶向活检的男性,比较两种活检方式的临床、MRI和活检特征。标准模板和靶向活检的总体癌症检出率分别为74.1%和63.5%,其中临床显著前列腺癌分别占52.5%和59.7%,联合临床显著前列腺癌检出率为62.2%。结论认为在mpMRI可疑病变男性中,联合活检的总体和临床显著前列腺癌检出率均高于单独任一方式。
要点
- 经会阴标准模板联合MRI融合靶向活检的临床显著前列腺癌检出率为62.2%。
- 标准模板与靶向活检的总体癌症检出率分别为74.1%和63.5%。
- 在mpMRI可疑病变时,经会阴活检应包含靶向联合标准模板。
核心结论
- 在mpMRI可疑病变男性中,经会阴MRI融合靶向活检联合标准模板的总体癌症和临床显著前列腺癌检出率均高于单独标准模板或靶向活检。
研究设计与样本
- 回顾性分析2019年9月至2021年2月接受经会阴标准20针模板联合mpMRI-超声融合靶向活检的301例男性。
- 比较标准模板与融合靶向活检的临床、MRI和活检特征。
主要发现
- 靶向病灶每例取3针靶向穿刺(IQR 3-4)。
- 标准模板和靶向活检的总体癌症检出率分别为74.1%和63.5%。
- 标准模板和靶向活检检出的癌症中临床显著前列腺癌分别占52.5%和59.7%。
- 联合临床显著前列腺癌检出率为62.2%。
- 两种方法均诊断癌症的176例中,靶向活检升级占18.8%,模板活检升级占18.2%。
临床怎么用
- 对mpMRI可疑前列腺病变的男性,经会阴穿刺应包含靶向活检联合标准模板。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Transperineal (TP) prostate biopsy provides an effective approach to prostate cancer (PCa) detection. Although transrectal targeted biopsy has been well described, the specific advantage of the standard TP template or TP targeted biopsy using multiparametric (mp) magnetic resonance imaging (MRI)-ultrasound (US) fusion remains less understood and without consensus. MATERIALS AND METHODS: We identified all men who underwent a transperineal standard 20-core template in addition to a targeted biopsy with mpMRI-US fusion-guided software from September 2019 to February 2021. We assessed and compared clinical, MRI and biopsy characteristics between standard TP template and fusion targeted biopsies. RESULTS: A total of 301 men underwent TP fusion biopsy during the study period. Target lesions on MRI were sampled with 3 targeted cores per patient (IQR 3-4). The overall cancer detection rate was 74.1% and 63.5% by standard template and targeted biopsy, respectively, of which 52.5% and 59.7% were clinically significant (cs) PCa. Combined csPCa detection rate was 62.2%. Of 176 cases with a cancer diagnosis by both biopsy methods, 18.8% were upgraded with targeted biopsies while 18.2% were upgraded with template biopsies. CONCLUSIONS: In men with suspicious lesions on mpMRI, TP MRI fusion-guided biopsies combined with standard template provide a higher overall cancer detection rate and higher detection rate of csPCa than the standard template or targeted biopsy alone. In the setting of a suspicious mpMRI prostate lesion, targeted plus standard template should be included as part of the TP biopsy procedure.
引用
- Kim MM, Wu S, Lin SX, et al. Transperineal Multiparametric Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy Combined with Standard Template Improves Prostate Cancer Detection. J Urol. 2021. PMID: 34428921. doi:10.1097/JU.0000000000002168
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。